124.204  Schedule I — substances included.
  1.  Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.
  2.  Opiates.  Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
  a.  Acetylmethadol.
  b.  Allylprodine.
  c.  Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-

acetylmethadol, levomethadyl acetate, or LAAM).
  d.  Alphameprodine.
  e.  Alphamethadol.
  f.  Alpha-Methylfentanyl (N-(1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl) 

propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine).
  g.  Benzethidine.
  h.  Betacetylmethadol.
  i.  Betameprodine.
  j.  Betamethadol.
  k.  Betaprodine.
  l.  Clonitazene.
  m.  Dextromoramide.
  n.  Difenoxin.
  o.  Diampromide.
  p.  Diethylthiambutene.
  q.  Dimenoxadol.
  r.  Dimepheptanol.
  s.  Dimethylthiambutene.
  t.  Dioxaphetyl butyrate.
  u.  Dipipanone.
  v.  Ethylmethylthiambutene.
  w.  Etonitazene.
  x.  Etoxeridine.
  y.  Furethidine.
  z.  Hydroxypethidine.
  aa.  Ketobemidone.
  ab.  Levomoramide.
  ac.  Levophenacylmorphan.
  ad.  Morpheridine.
  ae.  Noracymethadol.
  af.  Norlevorphanol.
  ag.  Normethadone.
  ah.  Norpipanone.
  ai.  Phenadoxone.
  aj.  Phenampromide.
  ak.  Phenomorphan.
  al.  Phenoperidine.
  am.  Piritramide.
  an.  Proheptazine.
  ao.  Properidine.
  ap.  Propiram.
  aq.  Racemoramide.
  ar.  Tilidine.
  as.  Trimeperidine.
  at.  Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-

3-methyl-4-piperidinyl]-N-phenylpropanamide).
  au.  Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-

 phenylacetamide).
  av.  Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-

 phenylpropanamide).
  aw.  Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-

 phenylpropanamide).
  ax.  3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-

 phenylpropanamide). For purposes of this opiate, “isomers” includes optical and geometric isomers.
  ay.  3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-

 phenylpropanamide).
  az.  MPPP (1-methyl-4-phenyl-4-propionoxy-piperidine).
  ba.  Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-

piperidinyl] propanamide).
  bb.  PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine).
  bc.  Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide).
  3.  Opium derivatives.  Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
  a.  Acetorphine.
  b.  Acetyldihydrocodeine.
  c.  Benzylmorphine.
  d.  Codeine methylbromide.
  e.  Codeine-N-Oxide.
  f.  Cyprenorphine.
  g.  Desomorphine.
  h.  Dihydromorphine.
  i.  Etorphine (except hydrochloride salt).
  j.  Heroin.
  k.  Hydromorphinol.
  l.  Methyldesorphine.
  m.  Methyldihydromorphine.
  n.  Morphine methylbromide.
  o.  Morphine methylsulfonate.
  p.  Morphine-N-Oxide.
  q.  Myrophine.
  r.  Nicocodeine.
  s.  Nicomorphine.
  t.  Normorphine.
  u.  Pholcodine.
  v.  Thebacon.
  w.  Drotebanol.
  4.  Hallucinogenic substances.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term “isomer” includes the optical, position and geometric isomers):
  a.  4-bromo-2,5-dimethoxy-amphetamine. 

Some trade or other names: 4-bromo-2,5-dimethoxy-a-methylphenethylamine; 4-

bromo-2,5-DMA.
  b.  2,5-dimethoxyamphetamine. Some trade or other names: 2,5-dimethoxy-a-

methylphenethylamine; 2,5-DMA.
  c.  4-methoxyamphetamine. Some trade or other names: 4-methoxy-a-

 methylphenethylamine; paramethoxyamphetamine, PMA.
  d.  5-methoxy-3,4-methylenedioxy-amphetamine.
  e.  4-methyl-2,5-dimethoxyl-amphetamine. Some trade or other names: 4-methyl-2,5-

dimethoxy-a-methylphenethylamine; “DOM”; and “STP”.
  f.  3,4-methylenedioxy amphetamine, also known as MDA.
  g.  3,4,5-trimethoxy amphetamine.
  h.  Bufotenine. Some trade or other names: 3-(B-Dimethylaminoethyl)-5-hydroxyindole;

 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-

dimethyltryptamine; mappine.
  i.  Diethyltryptamine. Some trade and other names:  N, N-Diethyltryptamine; DET.
  j.  Dimethyltryptamine. Some trade or other names:  DMT.
  k.  Ibogaine. Some trade or other names: 7-Ethyl-6,6B,7,8,9,10,12,13-octahydro-2-

methoxy-6,9-methano-5H-pyrido (1',2':1,2) azepino (5,4-b) indole; Tabernanthe iboga.
  l.  Lysergic acid diethylamide.
  m.  Marijuana, except as otherwise provided by rules of the board for medicinal purposes.
  n.  Mescaline.
  o.  Parahexyl. Some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-tetrahydro-6,6,9-

trimethyl-6H-dibenzo(b,d) pyran; synhexyl.
  p.  Peyote, except as otherwise provided in subsection 8. Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or extracts.
  q.  N-ethyl-3-piperidyl benzilate.
  r.  N-methyl-3-piperidyl benzilate.
  s.  Psilocybin.
  t.  Psilocyn.
  u.  Tetrahydrocannabinols, except as otherwise provided by rules of the board for medicinal purposes, meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (Cannabis plant) as well as synthetic equivalents of the substances contained in the Cannabis plant, or in the resinous extractives of such plant, and synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
  (1)  1 cis or trans tetrahydrocannabinol, and their optical isomers.
  (2)  6 cis or trans tetrahydrocannabinol, and their optical isomers.
  (3)  3,4 cis or trans tetrahydrocannabinol, and their optical isomers. (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)
  v.  Ethylamine analog of phencyclidine. Some trade or other names: 

N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE.
  w.  Pyrrolidine analog of phencyclidine. Some trade or other names: 

1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP.
  x.  Thiophene analog of phencyclidine. Some trade or other names: 1-(1-(2-thienyl)-

cyclohexyl)-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP.
  y.  1-[1-(2-thienyl)cyclohexyl]pyrrolidine. Some other names: TCPy.
  z.  3,4-methylenedioxymethamphetamine (MDMA).
  aa.  3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-

alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA).
  ab.  N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-

alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA).
  ac.  2,5-dimethoxy-4-ethylamphetamine. Some trade or other names: DOET.
  ad.  Alpha-ethyltryptamine. Some trade or other names: etryptamine; Monase;

 a-ethyl-1H-indole-3-ethanamine;3-(2-aminobutyl)indole; alpha-ET; and AET.
  ae.  4-Bromo-2,5-dimethoxyphenethylamine. Some trade or other names: 2-(4-bromo-

 2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.
  af.  2,5-dimethoxy-4-(n)-propylthiophenethylamine. Other name: 2C-T-7.
  ag.  Alpha-methyltryptamine. Other name: AMT.
  ah.  5-methoxy-N,N-diisopropyltryptamine. Other name: 5-MeO-DIPT.
  ai.  (1)  Mephedrone, also known as 4-methylmethcathinone,(RS)-2-

methylamino-l-(4-methylphenyl)propan-1-one.
  (2)  Methylene-dioxypyrovalerone(MDPV)[(1-(1,3-Benzodioxol-5-yl)-2-

(1-pyrrolidinyl)-1-pentanone].
  (3)  Salvia divinorum.
  (4)  Salvinorin A.
  (5)  Any substance, compound, mixture or preparation which contains any quantity of any synthetic cannabinoid that is not approved as a pharmaceutical, including but not limited to the following:
  (a)  CP 47, 497 and homologues 2-[(1R, 3S)-3-hydroxycyclohexyl]-5-

(2-methyloctan-2-yl)phenol).
  (b)  HU-210[(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-

6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol)].
  (c)  HU-211(dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-

(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
  (d)  JWH-018 1-Pentyl-3-(1-naphthoyl)indole.
  (e)  JWH-073 1-Butyl-3-(1-naphthoyl)indole.
  (f)  JWH-200[1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-1-

naphthalenyl-methanone.
  5.  Depressants.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
  a.  Mecloqualone.
  b.  Methaqualone.
  c.  Gamma-hydroxybutyric acid. Some trade or other names: GHB;

 gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate;

 sodium oxybutyrate.
  6.  Stimulants.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
  a.  Fenethylline.
  b.  N-ethylamphetamine.
  c.  (+-)cis-4-methylaminorex ((+-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine).
  d.  N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine;

 N,N-alpha-trimethylphenethylamine).
  e.  Cathinone. Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-

 aminopropiophenone, 2-aminopropiophenone, and norephedrone.
  f.  Aminorex. Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline;

 4,5-dihydro-5-phenyl-2-oxazolamine.
  g.  Methcathinone, its salts, optical isomers, and salts of optical isomers. 

Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone;

 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone;

 monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464;

 AL-422; AL-463; and UR1432.
  h.  N-benzylpiperazine. Some other names: BZP, 1-benzylpiperazine.
  7.  Exclusions.  This section does not apply to marijuana, tetrahydrocannabinols or chemical derivatives of tetrahydrocannabinol when utilized for medicinal purposes pursuant to rules of the board.
  8.  Peyote.  Nothing in this chapter shall apply to peyote when used in bona fide religious ceremonies of the Native American Church; however, persons supplying the product to the church shall register, maintain appropriate records of receipts and disbursements of peyote, and otherwise comply with all applicable requirements of this chapter and rules adopted pursuant thereto.
  9.  Other materials.  Any material, compound, mixture, or preparation which contains any quantity of the following substances:
  a.  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, 

salts and salts of isomers.
  b.  N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), 

its optical isomers, salts and salts of isomers.
[C73, 75, 77, 79, 81, §204.204; 82 Acts, ch 1044, §1, 2]
84 Acts, ch 1013, §4 – 8; 85 Acts, ch 86, §1, 2; 86 Acts, ch 1037, §1, 2; 87 Acts, ch 122, §1; 88 Acts, ch 1024, §1; 89 Acts, ch 109, §1, 2; 91 Acts, ch 8, §2

94 Acts, ch 1009, §2 – 8; 2000 Acts, ch 1140, §2 – 4; 2001 Acts, ch 58, §1; 2003 Acts, ch 53, §1 – 3; 2007 Acts, ch 8, §2 – 7; 2007 Acts, ch 10, §9 – 11; 2011 Acts, ch 131, §134 – 136; 2011 Acts, ch 134, §18, 27, 28
Criminal penalties for violations associated with substances designated as controlled substances under subsection 4, paragraph “ai”, subparagraphs (1) – (4) do not apply until 30 days after the enactment date of the subparagraphs; 2011 Acts, ch 131, §133, 136
2011 enactment of subsection 4, paragraph “ai”, subparagraphs (1) – (4) takes effect 30 days after July 29, 2011; 2011 Acts, ch 131, §134, 136; 2011 Acts, ch 134, §27
2011 amendment to subsection 4, paragraph “ai”, subparagraph (5) takes effect July 29, 2011; 2011 Acts, ch 131, §135, 136; 2011 Acts, ch 134, §28
Subsection 4, NEW paragraph ai